$74.19
▲ +0.0% Today
as of Jul 22, 16:56 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 1
● 24
▼ 0
Zoetis (ZTS) Stock Dips While Market Gains: Key Facts
Zoetis Earnings Preview: What to Expect
Zoetis Launches Lenivia® (izenivetmab injection) in Canada and the European Union
Overview
52-week range
$72
$172
2% of range
Avg surprise (last 3)
+3.1%
Avg reaction (last 2)
-13.3%
0% positive
Latest IV / EM
52%
EM ±12.0% · $75 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $1.53 | $1.61 | -5.0% | +3.4% | -21.5% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $1.63 | — | — | — | — | financials |
| Tue Aug 5, 2025 | Jun/2025 | $1.76 | $1.62 | +8.6% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $1.48 | $1.40 | +5.7% | — | -5.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $1.50 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $1.37 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $1.31 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $1.29 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $1.45 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | BMO | $1.85 | $1.76 | +5.1% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.26B | — | $2.40B | $2.46B | $2.20B | — | $2.39B | $2.36B |
| Cost of revenue | $641M | — | $683M | $649M | $618M | — | $701M | $668M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $601M | — | $721M | $718M | $602M | — | $682M | $624M |
| EPS (diluted) | $1.42 | — | $1.63 | $1.61 | $1.34 | — | $1.50 | $1.37 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.94B | $2.45B | $2.08B | $1.44B | $1.72B | $1.99B | $1.71B | $1.57B |
| Inventory | $2.55B | $2.46B | $2.46B | $2.44B | $2.37B | $2.31B | $2.42B | $2.45B |
| Total current assets | $6.47B | $6.77B | $6.58B | $5.92B | $5.88B | $5.99B | $6.28B | $6.20B |
| Total assets | $15.15B | $15.49B | $15.16B | $14.48B | $14.10B | $14.24B | $14.36B | $14.16B |
| Long-term debt | $9.04B | $9.04B | $7.07B | $5.23B | $5.23B | $5.22B | $6.57B | $6.56B |
| Total liabilities | $11.92B | $12.07B | $9.76B | $9.50B | $9.44B | $9.47B | $9.12B | $9.21B |
| Total equity | $3.23B | $3.42B | $5.40B | $4.98B | $4.66B | $4.77B | $5.23B | $4.97B |